Holen Sie sich die Stockscreener-App
1.50
1.96%
-0.03
Handel nachbörslich:
1.53
0.03
+2.00%
Schlusskurs vom Vortag:
$1.53
Offen:
$1.53
24-Stunden-Volumen:
790.96K
Relative Volume:
0.45
Marktkapitalisierung:
$137.20M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-67.68M
KGV:
-0.9036
EPS:
-1.66
Netto-Cashflow:
$-54.24M
1W Leistung:
-5.06%
1M Leistung:
-9.64%
6M Leistung:
-17.13%
1J Leistung:
-73.96%
1-Tages-Spanne:
$1.48
$1.55
1-Wochen-Bereich:
$1.48
$1.67
52-Wochen-Spanne:
$0.9857
$6.14
Cabaletta Bio Inc Stock (CABA) Company Profile
Firmenname
Cabaletta Bio Inc
Sektor
Branche
Telefon
(267) 759-3100
Adresse
2929 ARCH STREET, PHILADELPHIA, PA
Vergleichen Sie CABA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CABA
Cabaletta Bio Inc
|
1.50 | 139.94M | 0 | -67.68M | -54.24M | -1.66 |
|
VRTX
Vertex Pharmaceuticals Inc
|
389.08 | 99.27B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
586.96 | 62.28B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.18 | 59.14B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
707.96 | 43.34B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
300.14 | 36.72B | 3.81B | -644.79M | -669.77M | -6.24 |
Cabaletta Bio Inc Stock (CABA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-12-20 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2024-12-19 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2024-10-10 | Eingeleitet | UBS | Buy |
| 2024-02-05 | Eingeleitet | Jefferies | Buy |
| 2023-11-29 | Eingeleitet | William Blair | Outperform |
| 2023-10-24 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-10-19 | Eingeleitet | Stifel | Buy |
| 2023-09-05 | Eingeleitet | Citigroup | Buy |
| 2023-07-18 | Eingeleitet | Guggenheim | Buy |
| 2023-01-27 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2022-08-30 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2021-12-08 | Eingeleitet | Wells Fargo | Overweight |
| 2021-10-19 | Fortgesetzt | Morgan Stanley | Overweight |
| 2021-06-30 | Eingeleitet | Mizuho | Buy |
| 2021-01-08 | Eingeleitet | Chardan Capital Markets | Buy |
| 2020-10-13 | Eingeleitet | H.C. Wainwright | Buy |
| 2019-11-19 | Eingeleitet | Cowen | Outperform |
| 2019-11-19 | Eingeleitet | Evercore ISI | Outperform |
| 2019-11-19 | Eingeleitet | Morgan Stanley | Overweight |
Alle ansehen
Cabaletta Bio Inc Aktie (CABA) Neueste Nachrichten
Should you wait for a breakout in Cabaletta Bio Inc.Weekly Trade Review & Daily Profit Maximizing Tips - Newser
Live market analysis of Cabaletta Bio Inc.Swing Trade & Expert Curated Trade Setups - Newser
Cabaletta Bio Inc. stock prediction for this weekWeekly Stock Report & Consistent Return Investment Signals - Newser
Can Cabaletta Bio Inc. rally from current levelsJuly 2025 Trade Ideas & Weekly High Conviction Trade Ideas - Newser
Autoimmune Cell Therapy Pioneer Cabaletta Bio Featured at Morgan Stanley, Wells Fargo Healthcare Events - Stock Titan
What MACD and RSI say about Cabaletta Bio Inc.2025 Top Decliners & Daily Entry Point Alerts - Newser
Will Cabaletta Bio Inc. rebound enough to break evenJuly 2025 Spike Watch & Growth Focused Stock Reports - Newser
Is Cabaletta Bio Inc. stock a buy or sell getLinesFromResByArray error: size == 0 - 더경남뉴스
Cabaletta Bio Inc.’s volatility index tracking explainedAnalyst Downgrade & Risk Managed Trade Strategies - Newser
Using economic indicators to assess Cabaletta Bio Inc. potentialJuly 2025 Selloffs & Technical Entry and Exit Alerts - Newser
Is Cabaletta Bio Inc. forming a reversal patternQuarterly Investment Review & Real-Time Buy Zone Alerts - Newser
Analyzing recovery setups for Cabaletta Bio Inc. investorsGap Down & Daily Profit Maximizing Tips - Newser
What’s the recovery path for long term holders of Cabaletta Bio Inc.Stock Surge & Scalable Portfolio Growth Ideas - Newser
What moving averages say about Cabaletta Bio Inc.Weekly Trend Recap & Short-Term Swing Trade Alerts - Newser
Custom strategy builders for tracking Cabaletta Bio Inc.2025 Biggest Moves & Free Safe Capital Growth Stock Tips - Newser
Is Cabaletta Bio Inc. still worth holding after the dip2025 Market Sentiment & Fast Moving Market Watchlists - Newser
How hedge fund analytics apply to Cabaletta Bio Inc. stockJuly 2025 Weekly Recap & Expert Curated Trade Ideas - Newser
Can machine learning forecast Cabaletta Bio Inc. recoveryGlobal Markets & Community Shared Stock Ideas - Newser
Resistance Break Could Fuel Cabaletta Bio Inc. RallyRate Hike & Reliable Breakout Forecasts - sundaytimes.kr
Top chart patterns to watch in Cabaletta Bio Inc.Trend Reversal & Accurate Entry/Exit Alerts - Newser
Analyzing drawdowns of Cabaletta Bio Inc. with statistical toolsWeekly Market Outlook & Smart Investment Allocation Tips - Newser
How volatile is Cabaletta Bio Inc. stockJuly 2025 Rallies & Reliable Trade Execution Plans - theviewers.co.kr
What are Cabaletta Bio Inc.’s recent SEC filings showing2025 Key Lessons & Weekly High Return Forecasts - theviewers.co.kr
Market reaction to Cabaletta Bio Inc.’s recent newsJuly 2025 Pullbacks & Risk Adjusted Buy/Sell Alerts - Newser
Aug Catalysts: What analysts say about Cabaletta Bio Inc. stockInsider Selling & Real-Time Volume Trigger Notifications - theviewers.co.kr
Cabaletta Bio Inc. Flashes Rebound Signal in Oversold ConditionQuarterly Market Summary & Reliable Price Breakout Signals - beatles.ru
Dow Update: What are Cabaletta Bio Inc.’s recent SEC filings showingWeekly Profit Recap & Proven Capital Preservation Methods - sundaytimes.kr
What’s the beta of Cabaletta Bio Inc. stockDollar Strength & Real-Time Sentiment Analysis - theviewers.co.kr
Is Cabaletta Bio Inc.’s ROIC above industry averageJuly 2025 PreEarnings & Consistent Profit Alerts - theviewers.co.kr
Cabaletta Bio Inc. Shows Support at Fibonacci Level2025 Growth vs Value & Intraday High Probability Alerts - beatles.ru
Heatmap Data Shows High Activity in Cabaletta Bio Inc. Sector2025 Valuation Update & Daily Profit Focused Screening - newsyoung.net
Published on: 2025-08-20 09:42:53 - beatles.ru
Myasthenia Gravis Pipeline 2025: Key Companies, MOA, ROA, and Clinical Trials Evaluation by DelveInsight | Alpine Immune Science, Toleranzia, Cabaletta Bio, Rallybio, Alexion Pharma, Takeda - The Globe and Mail
Using Ichimoku Cloud for Cabaletta Bio Inc. technicalsJuly 2025 Gainers & Growth Focused Entry Reports - Newser
Cabaletta Bio (CABA) Q2 Loss Widens 30% - AOL.com
Is Cabaletta Bio Inc. in Accumulation Phase Now2025 Macro Impact & Risk Controlled Swing Alerts - beatles.ru
Applying big data sentiment scoring on Cabaletta Bio Inc.July 2025 Sector Moves & Fast Entry and Exit Trade Plans - Newser
How to track smart money flows in Cabaletta Bio Inc.July 2025 Volume & AI Driven Stock Reports - Newser
Sentiment Tools Show Shift in Trader Mood on Cabaletta Bio Inc.2025 Sector Review & Community Driven Trade Alerts - beatles.ru
Will Cabaletta Bio Inc. Stock Benefit from AI and Green Energy TrendsOil Prices & Daily Momentum Trading Reports - Newser
Why is Cabaletta Bio Inc. stock going upVolume Spike & Accurate Buy Signal Notifications - mustnews.co.kr
Is Cabaletta Bio Inc. stock a buy or sellWatch List & Risk Controlled Stock Alerts - mustnews.co.kr
Finanzdaten der Cabaletta Bio Inc-Aktie (CABA)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.98%
8.06%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):